Shares of Novavax Inc. /zigman2/quotes/202614340/composite NVAX -1.08% climbed 13.00% to $93.70 Monday, on what proved to be an all-around great trading session for the stock market, with the NASDAQ Composite Index /zigman2/quotes/210598365/realtime COMP -0.23% rising 3.41% to 14,239.88 and the Dow Jones Industrial Average /zigman2/quotes/210598065/realtime DJIA +1.47% rising 1.17% to 35,131.86. This was the stock's second consecutive day of gains. Novavax Inc. closed $237.98 short of its 52-week high ($331.68), which the company achieved on February 9th.
The stock outperformed some of its competitors Monday, as Replimune Group Inc. /zigman2/quotes/203971249/composite REPL -1.24% rose 6.56% to $19.83, VBI Vaccines Inc. /zigman2/quotes/201705917/lastsale VBIV +0.84% rose 6.25% to $1.70, and AnaptysBio Inc. /zigman2/quotes/205822596/composite ANAB +0.43% rose 2.21% to $31.97. Trading volume (10.4 M) eclipsed its 50-day average volume of 6.4 M.